News|Videos|November 1, 2023
Seamless Patient Transitions in Prostate Cancer Care
Author(s)David Morris, MD, FACS , Benjamin Garmezy, MD
Experts share insights into collaborative relay strategies between urologists and medical oncologists that ensure smooth handoffs and continued care for patients with prostate cancer receiving combination therapies.
Advertisement
Episodes in this series
Newsletter
Stay up to date on practice-changing data in community practice.
SubscribeAdvertisement
Related to this article
VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively.
Interim phase 2 results show carotuximab plus apalutamide sharply extends progression-free survival in metastatic castration-resistant prostate cancer, prompting earlier-use trial changes.
Digital biopsy data show CAN-2409 plus radiation boosts durable lymphocyte-tumor engagement in localized prostate cancer, hinting at stronger immune surveillance and better control.
Advertisement
Advertisement